Your patient walked out of ketamine session 3 lighter than they've felt in years. The fog lifted. They smiled at the front desk for the first time since their intake.
Then session 4 came. And the chair stayed empty.
This is the quiet heartbreak of interventional psychiatry. Not the patient who never responds to treatment, but the one who responds beautifully, then disappears mid-protocol. The neuroplasticity window starts closing. The momentum stalls.
By the time your team reaches them by phone two days later, the rhythm of the protocol is broken.
Here's what makes this so frustrating: it's almost never about the treatment failing. It's about the communication system failing.
The Osmind app sits on a phone that the patient hasn't opened in days because their depression makes opening apps feel impossible. The reminder notification gets buried under social media alerts and email pings. The patient who needs the reminder most is the one least likely to see it.
Interventional psychiatry serves patients whose conditions actively interfere with the behaviors needed to complete treatment.
Treatment-resistant depression dulls motivation. PTSD creates avoidance. Chronic pain limits planning. Asking these patients to actively check an app to stay on protocol is asking them to do the exact thing their illness makes hardest.
This is where SMS reminders treatment protocol adherence ketamine TMS patients Osmind becomes more than an operational question. It becomes a clinical one.
A text message arrives passively. It shows up on the lock screen patients check 80+ times a day. It requires no login, no engagement, no app open.
For Osmind practices, that one channel can be the difference between a completed protocol and a broken one. Let's unpack why.
Interventional psychiatry isn't like a missed therapy session you can reschedule next Tuesday without clinical consequence. The treatment mechanism itself depends on session timing. Stretch the gap, and you stretch the result.
Ketamine builds its antidepressant effect through closely spaced infusions.
Each session opens a neuroplasticity window the next session reinforces. Insert a 9-day gap into a protocol designed for every-other-day spacing, and you're no longer running the protocol the evidence supports.
TMS follows the same logic. Consecutive daily sessions create cumulative cortical changes. Skip three days mid-protocol and the cortical stimulation from the previous treatment fades before the next one builds on it.
The drop-off pattern is also predictable. Industry data on multi-session psychiatric protocols suggests patient dropout ranges from 20% to 40%, with most attrition happening in the middle sessions, not the first or the last.
That mid-protocol cluster is where three forces collide at once:
None of those forces show up on a chart. They show up as empty chairs.
Think about a single TMS patient who completes 20 of 36 sessions.
At $250–$350 per session, that's $4,000 to $5,600 in lost protocol revenue from one chair. Now multiply that by even five drop-off patients in a quarter, and the math gets uncomfortable fast.
| Protocol Type | Sessions Required | Typical Per-Session Revenue | Revenue Lost Per Mid-Protocol Drop-Off |
|---|---|---|---|
| Ketamine series | 6 sessions | $400–$800 | $1,200–$3,200 |
| TMS protocol | 36 sessions | $250–$350 | $4,000–$5,600 |
| Spravato | 8 sessions (induction) | $600–$900 | $2,400–$5,400 |
For your team, that's not just revenue lost. It's clinical outcome lost.
A patient who paid for hope and got partial treatment may have invested in something that never reached therapeutic threshold, not because the treatment doesn't work, but because attendance gaps compromised the mechanism of action.
This is the appointment adherence interventional psychiatry SMS reminders gap that no clinical excellence alone can close. The treatment can be perfect. If the patient doesn't arrive, the protocol breaks.
Osmind does what it was built to do beautifully. It tracks the clinical protocol. It documents outcomes. It supports your charting workflow. But the app-based reminder model has a structural blind spot: it only reaches patients who open the app.
Walk through who's most likely to open the app: engaged, organized patients with stable mood, intact executive function, and a habit of checking notifications. In other words, the patients least at risk of missing a session in the first place.
Now consider who's least likely to open the app:
These are the patients the reminder system needs to reach. These are the patients the app misses.
Here's the uncomfortable inverse: app engagement and clinical need run in opposite directions.
The sicker the patient, the less they engage with the app. The less they engage, the more invisible their reminders become. The more invisible the reminders, the higher their dropout risk.
It's a system that quietly selects against the patients who need protocol support the most. And it's not Osmind's fault. No EMR app is designed to function as a behavioral intervention. That's a different tool, with a different job.
SMS bypasses the engagement requirement entirely.
A text shows up whether the patient opens an app or not. It arrives on the screen they check reflexively, dozens of times a day, often without realizing they're doing it. That passive visibility is the entire point.
Here's where Curogram fits. It's not a replacement for Osmind. It's the communication layer Osmind doesn't try to be.
Osmind tracks your clinical protocol:
The treatment plan, the session documentation, the outcome measures.
Curogram handles the patient's path to the chair:
The reminders, the confirmations, the follow-ups when they go quiet. Two systems, complementary jobs.
The TMS protocol no-show prevention Osmind patients piece works through automated, HIPAA-compliant SMS sequences that match your treatment cadence.
A ketamine patient gets reminders timed to their every-other-day schedule.
A TMS patient gets daily reminders that match their consecutive-session protocol.
A Spravato patient gets reminders that include the post-dose monitoring period.
Curogram's reminder templates are fully customizable, which means they can do more than just say "you have an appointment tomorrow." They can carry context that supports adherence.
Each message is a small behavioral nudge. None of them require the patient to open an app, log in, or actively engage. The reminder shows up. The patient reads it without thinking about it. The protocol stays intact.
For your team, that means the ketamine infusion series completion rate text reminders question stops being a hope and becomes a workflow.
You stop relying on the patient to remember a difficult appointment during their hardest week. You let the system carry them through.
| Function | Osmind | Curogram |
|---|---|---|
| Treatment plan documentation | Yes | No |
| Session-level clinical notes | Yes | No |
| Outcome tracking | Yes | No |
| Automated SMS reminders | App-based only | Yes, true SMS |
| Two-way patient texting | Limited | Yes |
| Confirmation and no-show tracking dashboard | Limited | Yes |
There's no data conflict, no workflow disruption, no double entry. Curogram operates as a seamless add-on that handles the communication layer while Osmind owns the clinical record.
Curogram clients in psychiatry see an 11.03% no-show rate versus the 23% industry average. That's a 52% reduction in missed appointments.
For a protocol-dependent specialty, those numbers translate directly into three compounding wins:
Atlas Medical Center pushed it further. They dropped from a 14.20% no-show rate to 4.91% in three months. That means 95% of scheduled sessions filled.
For an interventional practice, that's the difference between protocols that limp to a finish and protocols that hit the clinical benchmarks they were designed to hit.
~32 of 36 sessions Average sessions completed per TMS protocol at Curogram's 11% no-show rate, versus ~28 of 36 at the industry-average 23% no-show rate.
Those four extra sessions are often what gets a patient across the therapeutic threshold.
Let's run the math on a hypothetical TMS practice putting 200 patients through full 36-session protocols per year.
With a 23% industry-average no-show rate, only around 120 of those patients reach the full 36 sessions, and estimated annual protocol revenue lost climbs past $200,000.
At Curogram's 11% no-show rate, that lost revenue drops to roughly $50,000–$70,000.
This means a practice running 200 protocols a year could retain six figures in revenue simply by closing the communication gap.
In practice, that's the salary of a senior tech, the cost of a second TMS chair, or the runway to expand into Spravato. The numbers move because the patients show up.
For your team, the bigger story is the patient retention interventional psychiatry automated reminders effect. Patients who complete protocols become patients who refer other patients. Patients who drop off mid-protocol rarely come back, and they rarely refer.
Consider a patient with treatment-resistant depression starting a ketamine series. Session 1 happens. The Curogram reminder went out the night before and the morning of. Patient confirmed both.
Sessions 2 and 3 follow the same rhythm. By session 4, the patient is having a hard week. They haven't opened any app in three days. But the text arrived at 6 PM the night before and again at 8 AM the morning of. They saw both on their lock screen. They came in.
Session 6 closes the protocol. The patient reports the best sustained mood improvement they've experienced in years. The treatment worked because the patient completed it. The patient completed it because the reminder met them where their condition allowed them to be reached.
That's the entire treatment-resistant depression appointment attendance SMS story in one arc.
Your treatment protocols are clinically sound. Your providers are skilled. Your Osmind workflow handles the documentation. The missing piece isn't medical, it's behavioral, and it lives in the gap between session 3 and session 4.
That gap closes when the reminder system stops requiring active engagement and starts meeting patients on the channel their condition actually allows them to use. Text arrives. Patient sees it. Patient comes in. The protocol stays whole.
Curogram exists to be that layer. HIPAA-compliant SMS reminders that integrate with Osmind, match your treatment cadence, and reach patients on bad days, not just good ones.
A 52% reduction in no-shows isn't a marketing number. It's hundreds of patients who completed their protocols instead of stalling out at session 4.
For interventional psychiatry, that's not an operational upgrade. It's a clinical safety net.
Schedule a Demo to See this in your Workflow. Bring your hardest scheduling problem, and we'll show you what the bridge looks like in your practice.